Generally, hepatic de novo synthesis of FFA is relatively low; however, in the presence of glucose and lipid metabolism disorders, an abnormal increase in de novo synthesis in the liver is observed, leading to FFA and DAG accumulation in hepatocytes and direct impairment of the insulin signaling pathway (Besse-Patin et al., 2019). Here, INS is linked to Disorder of lipid metabolism.